Montreal, February 17, 2026 - Mila is pleased to announce a new partnership with AI4Eyes, a Canadian AI-powered Software as a Medical Device (SaMD) that integrates clinical-grade imaging, diagnostics, treatment and care recommendations into one single platform. This strategic collaboration will focus on accelerating the development of next-generation AI applications in eye care by combining Mila’s world-class expertise in machine learning and deep learning with AI4Eyes’ patented SaMD platform and deep clinical eye care expertise. Together, the partners will advance AI-driven diagnostics, treatment decisions, and care recommendations with meaningful real-world clinical impact.
“At Mila, we are dedicated to translating cutting-edge AI research into practical outcomes,” said Stéphane Létourneau, Executive Vice-President of Mila. “AI4Eyes’ innovative SaMD platform, paired with our leadership in advanced AI, creates a promising foundation for driving forward AI-assisted diagnostic insights and treatment planning in the field of ophthalmology.”
“Partnering with Mila allows AI4Eyes to leverage world-class research in machine learning and deep learning,” added Tara Akhavan, PhD, CEO of AI4Eyes. “Together, we will accelerate innovation and transform how eye care is diagnosed, treated, and delivered, ultimately improving outcomes for patients everywhere.”
About Mila – Quebec Artificial Intelligence Institute
Founded by Professor Yoshua Bengio, Mila – Quebec Artificial Intelligence Institute is the world’s largest academic AI research center specialized in deep learning, home to a community over 1500 strong. Based in Montreal, Mila was created out of a unique partnership between Université de Montréal and McGill University, dedicated to advancing scientific breakthroughs that drive innovation and ensure AI benefits everyone. A non-profit organization, Mila is strongly supported by the Government of Canada through the Pan-Canadian AI Strategy and by the Government of Quebec. Internationally recognized for its influential research, global innovation partnerships, and leadership in multilateral efforts on responsible AI, Mila continues to shape the future of AI worldwide. For more information, visit mila.quebec.
About AI4Eyes
AI4Eyes offers a modular AI-powered SaMD making eye care smarter, faster and more accurate for everyone, everywhere. Specifically, the company integrates clinical-grade imaging, diagnostics, treatment and care recommendations into a single platform. Designed to enhance both clinical efficiency and patient outcomes, the platform enables eye care professionals to deliver high-quality, data-driven care with unprecedented speed and accuracy.
Starting with Dry Eye Disease, AI4Eyes is expanding into corneal health and myopia management, building a comprehensive, AI-driven ecosystem for eye care.
